A method of decreasing concentration of tau (τ) protein and/or phosphorylated tau (τ) protein
GB202005985D0
Sars-Cov-2 Diagnostic control compositions
WO2020183422A1
Compounds having excited state intramolecular proton transfer (esipt) character for use in treating and/or preventing sunburn and/or preventing u.v. damage
WO2020157651A1
2-HYDROXYPROPYL-β-CYCLODEXTRIN (HPβCD) FOR USE IN THE TREATMENT OF BREAST CANCER
WO2020110067A1
Compounds for use in the treatment of parkinson's disease
WO2020075132A1
Systems, methods, and an apparatus for controlling a sleep environment and waking a sleeping person
WO2020008442A2
Biopharmaceutical agents for use in reducing lipid content in cells
ZA201902888B
A system and method for determining spontaneous combustion propensity of carbonaceous materials
WO2019211746A1
Thermal radiation loss reduction in a parabolic trough receiver by the application of a cavity mirror and a hot mirror coating
US2020405821A1
Pharmaceutical composition
US2020326334A1
A nanoparticle-based telomerase assay
US2020299843A1
Method of applying an antimicrobial surface coating to a substrate
ZA201804247B
Dc microgrid device and electricity distribution network
WO2018142299A1
A thermoresponsive hydrogel
WO2018134799A1
A method and system for hybrid classical-quantum communication
ZA201704191B
Petrol - ethanol mixtures
US2019145821A1
Method and system for measuring beam quality of a laser beam
NL2018981B1
Method and system for improving the surface fracture toughness of brittle materials, and a cutting tool produced by such method
WO2017178992A1
Imidazo[1,2-a]pyridine complexes with anticancer activity
EP3436603A1
Genetically modified strains of mycobacterium smegmatis
